Journal article icon

Journal article

EDH: Endothelium-dependent hyperpolarization and microvascular signaling.

Abstract:
Endothelium-dependent hyperpolarizing factor (EDHF) is a powerful vasodilator influence in small resistance arteries and thus an important modulator of blood pressure and flow. As the name suggests, EDHF was thought to describe a diffusible factor stimulating smooth muscle hyperpolarization (and thus vasodilatation). However, this idea has evolved with the recognition that a factor(s) can operate the spread of hyperpolarizing current from the endothelium to the vascular smooth muscle (VSM). As such, the pathway is now termed endothelium-dependent hyperpolarization (EDH). EDH is activated by an increase in endothelial [Ca(2+) ]i , which stimulates two Ca(2+) -sensitive K-channels, SKC a and IKC a . This was discovered because apamin and charybdotoxin applied in combination blocked EDHF responses, but iberiotoxin a blocker of BKC a was not able to substitute for charybdotoxin. SKC a and IKC a channels are arranged in endothelial microdomains, particularly within projections toward the adjacent smooth muscle, which are rich in IKC a channels, and close to inter-endothelial gap junctions where SKC a is prevalent. KC a activation hyperpolarizes endothelial cells, and K(+) efflux through them can act as a diffusible 'EDHF' by stimulating VSM Na(+) /K(+) -ATPase and inwardly-rectifying K-channels (KIR ). In parallel, hyperpolarizing current spreads from the endothelium to the smooth muscle through myoendothelial gap junctions located on endothelial projections. The resulting radial EDH is complemented by spread of 'conducted' hyperpolarization along the endothelium of arteries and arterioles to affect conducted vasodilatation (CVD). Retrograde CVD effectively integrates blood flow within the microcirculation, but how the underlying hyperpolarization is sustained is unclear. This article is protected by copyright. All rights reserved.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1111/apha.12649

Authors

More by this author
Institution:
University of Oxford
Oxford college:
Magdalen College
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author


Royal Society More from this funder
Funding agency for:
Garland, C
Grant:
Wolfson Research Merit Award
British Heart Foundation More from this funder
Funding agency for:
Dora, K
Grant:
Senior Basic Science Research Fellow
Stiftelsen Nordisk Fysiologi More from this funder
Wellcome Trust More from this funder


Publisher:
Wiley
Journal:
Acta Physiologica More from this journal
Volume:
219
Issue:
1
Pages:
152-161
Publication date:
2016-01-01
Acceptance date:
2016-01-06
DOI:
EISSN:
1748-1716
ISSN:
1748-1708
Pmid:
26752699


Language:
English
Keywords:
Pubs id:
pubs:589115
UUID:
uuid:21c481ec-3e9c-4ea8-9520-c5b6ec9ba9d1
Local pid:
pubs:589115
Source identifiers:
589115
Deposit date:
2017-04-22
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP